NASDAQ:BPMC
Delisted

Blueprint Medicines Stock News

etoro logo Buy BPMC
*Your capital is at risk
$129.46
+0 (+0%)
At Close: Oct 17, 2025
Wall Street brokerages expect that Blueprint Medicines Corp (NASDAQ:BPMC) will report sales of $4.83 million for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have
Blueprint Medicines Corp (NASDAQ:BPMC) insider Marion Dorsch sold 1,214 shares of the firm’s stock in a transaction dated Monday, March 23rd. The stock was sold at an average price of $52.49, for a
Alliancebernstein L.P. lifted its holdings in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 5.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commissi
Blueprint Medicines Corp (NASDAQ:BPMC) CEO Jeffrey W. Albers sold 20,000 shares of the stock in a transaction dated Monday, March 23rd. The stock was sold at an average price of $52.10, for a total tr
Blueprint Medicines Corp (NASDAQ:BPMC) shares traded down 5.1% during mid-day trading on Friday following insider selling activity. The company traded as low as $56.95 and last traded at $58.11, 843,3
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Great West Life Assurance Co. Can boosted its position in Blueprint Medicines Corp (NASDAQ:BPMC) by 9.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exch
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has submitted a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for avaprit
Amalgamated Bank increased its position in Blueprint Medicines Corp (NASDAQ:BPMC) by 5.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i
Blueprint Medicines Corp (NASDAQ:BPMC) shares traded up 14.9% during trading on Tuesday . The stock traded as high as $59.00 and last traded at $58.95, 668,014 shares traded hands during mid-day tradi
Blueprint achieved positive results from phase 2 study using avapritinib to treat patients with indolent systemic mastocytosis; Part 2 of study using 25 mg QD t
Blueprint Medicines added to Best Ideas List at Wedbush Wedbush BPMC
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE